دورية أكاديمية
أعرض في EDS

Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.

التفاصيل البيبلوغرافية
العنوان: Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.
المؤلفون: Witt Udsen F; Danish Centre for Healthcare Improvements, Aalborg University, Aalborg, Denmark., Lilholt PH; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Hejlesen O; Department of Health Science and Technology, Aalborg University, Aalborg, Denmark., Ehlers L; Danish Centre for Healthcare Improvements, Aalborg University, Aalborg, Denmark.
المصدر: BMJ open [BMJ Open] 2017 May 17; Vol. 7 (5), pp. e014616. Date of Electronic Publication: 2017 May 17.
نوع المنشور: Journal Article; Randomized Controlled Trial
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
مواضيع طبية MeSH: Cost-Benefit Analysis*, Pulmonary Disease, Chronic Obstructive/*economics , Pulmonary Disease, Chronic Obstructive/*therapy , Telemedicine/*economics, Aged ; Denmark ; Female ; Humans ; Male ; Middle Aged ; Quality of Life ; Quality-Adjusted Life Years ; Respiratory Function Tests
مستخلص: Objectives: To investigate the cost-effectiveness of a telehealthcare solution in addition to usual care compared with usual care.
Design: A 12-month cost-utility analysis conducted alongside a cluster-randomised trial.
Setting: Community-based setting in the geographical area of North Denmark Region in Denmark.
Participants: 26 municipality districts define randomisation clusters with 13 districts in each arm. 1225 patients with chronic obstructive pulmonary disease were enrolled, of which 578 patients were randomised to telehealthcare and 647 to usual care.
Interventions: In addition to usual care, patients in the intervention group received a set of telehealthcare equipment and were monitored by a municipality-based healthcare team. Patients in the control group received usual care.
Main Outcome Measure: Incremental costs per quality-adjusted life-years gained from baseline up to 12 months follow-up.
Results: From a healthcare and social sector perspective, the adjusted mean difference in total costs between telehealthcare and usual care was €728 (95% CI -754 to 2211) and the adjusted mean difference in quality-adjusted life-years gained was 0.0132 (95% CI -0.0083 to 0.0346). The incremental cost-effectiveness ratio was €55 327 per quality-adjusted life-year gained. Decision-makers should be willing to pay more than €55 000 to achieve a probability of cost-effectiveness >50%. This conclusion is robust to changes in the definition of hospital contacts and reduced intervention costs. Only in the most optimistic scenario combining the effects of all sensitivity analyses, does the incremental cost-effectiveness ratio fall below the UK thresholds values (€21 068 per quality-adjusted life-year).
Conclusions: Telehealthcare is unlikely to be a cost-effective addition to usual care, if it is offered to all patients with chronic obstructive pulmonary disease and if the willingness-to-pay threshold values from the National Institute for Health and Care Excellence are applied.
Trial Registration: Clinicaltrials.gov, NCT01984840, 14 November 2013.
Competing Interests: Competing interests: None declared.
(© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
References: Lancet. 2015 Aug 22;386(9995):743-800. (PMID: 26063472)
Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61. (PMID: 22561964)
Biom J. 2011 Feb;53(1):57-74. (PMID: 21259309)
Qual Health Res. 2004 Jul;14(6):760-78. (PMID: 15200799)
BMJ Open. 2016 Sep 26;6(9):e012355. (PMID: 27670521)
J Telemed Telecare. 2014 May 6;20(4):212-220. (PMID: 24803277)
Scand J Caring Sci. 2013 Dec;27(4):905-12. (PMID: 23121503)
J Telemed Telecare. 2015 Mar;21(2):108-18. (PMID: 25586810)
BMJ. 2013 Mar 20;346:f1035. (PMID: 23520339)
Health Econ. 2005 Dec;14(12):1217-29. (PMID: 15945043)
Med Decis Making. 2012 Mar-Apr;32(2):350-61. (PMID: 22016450)
Int J Technol Assess Health Care. 2009 Jul;25(3):339-49. (PMID: 19619353)
BMJ Open. 2015 Feb 06;5(2):e006448. (PMID: 25659890)
Lancet. 2007 Sep 1;370(9589):765-73. (PMID: 17765526)
Value Health. 2015 Mar;18(2):161-72. (PMID: 25773551)
Med Decis Making. 2013 Nov;33(8):1051-63. (PMID: 23913915)
Eur Respir J. 2009 May;33(5):1165-85. (PMID: 19407051)
Trials. 2014 May 21;15:178. (PMID: 24886225)
COPD. 2006 Dec;3(4):211-8. (PMID: 17361502)
J Glob Health. 2015 Dec;5(2):020415. (PMID: 26755942)
Eur Respir J. 2009 Feb;33(2):411-8. (PMID: 18799512)
COPD. 2012 Feb;9(1):46-57. (PMID: 22292597)
Chest. 2014 May;145(5):945-949. (PMID: 24798834)
Health Policy. 2007 Jul;82(2):133-41. (PMID: 17046097)
J Telemed Telecare. 2010;16(3):120-7. (PMID: 20197355)
Health Econ. 2005 May;14(5):487-96. (PMID: 15497198)
Eur Respir J. 2015 May;45(5):1239-47. (PMID: 25837037)
Telemed J E Health. 2012 Nov;18(9):688-92. (PMID: 23020647)
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD007718. (PMID: 21735417)
Pharmacoeconomics. 2014 Dec;32(12):1157-70. (PMID: 25069632)
BMJ. 2009 Jun 29;338:b2393. (PMID: 19564179)
Pharmacoeconomics. 2009;27(6):519-28. (PMID: 19640014)
Eur Respir J. 2009 May;33(5):1031-8. (PMID: 19129289)
Am J Manag Care. 2009 May;15(5):313-20. (PMID: 19435399)
Arch Fam Med. 2000 Jan;9(1):40-5. (PMID: 10664641)
J Telemed Telecare. 2015 Mar;21(2):80-7. (PMID: 25586812)
Scand J Public Health. 2009 Jul;37(5):459-66. (PMID: 19411320)
Cost Eff Resour Alloc. 2007 Sep 06;5:12. (PMID: 17822546)
J Telemed Telecare. 2012 Jan;18(1):1-6. (PMID: 22101609)
BJPsych Open. 2016 Aug 9;2(4):262-269. (PMID: 27703785)
Health Econ. 2004 May;13(5):437-52. (PMID: 15127424)
فهرسة مساهمة: Keywords: COPD; Cost-effectiveness; Denmark; Economic Evaluation; RCT; Telecare; Telehealth; Telemonitoring
سلسلة جزيئية: ClinicalTrials.gov NCT01984840
تواريخ الأحداث: Date Created: 20170519 Date Completed: 20180314 Latest Revision: 20231112
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC5541337
DOI: 10.1136/bmjopen-2016-014616
PMID: 28515193
قاعدة البيانات: MEDLINE
الوصف
تدمد:2044-6055
DOI:10.1136/bmjopen-2016-014616